The SAPHO syndrome - Are microbes involved?

被引:61
作者
Assmann, G. [1 ]
Simon, P. [1 ]
机构
[1] Univ Saarland, Sch Med, Jose Carreras Res Ctr, D-66421 Homburg, Germany
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2011年 / 25卷 / 03期
关键词
SAPHO; Synovitis; Acne; Pustulosis; Hyperostosis; Osteitis; Spondylarthropathy; Propionibacterium acnes; Tumour necrosis factor-alpha; RECURRENT MULTIFOCAL OSTEOMYELITIS; INFLAMMATORY-BOWEL-DISEASE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; HYPEROSTOSIS-OSTEITIS SYNDROME; PROPIONIBACTERIUM-ACNES; PSORIATIC-ARTHRITIS; HELICOBACTER-PYLORI; SUSTAINED RESPONSE; SINGLE-CENTER; FOLLOW-UP;
D O I
10.1016/j.berh.2011.01.017
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The syndrome of synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) includes a rare group of chronic, relapsing, inflammatory osteoarticular disorders that is conventionally associated with manifestations in the skin. Diagnostic dilemmas can arise due to incomplete manifestations or confusion generated through mimicking of other conditions, such as osteomyelitis. The aetiology of this syndrome remains unclear, but probably involves genetic, immunological and infectious mechanisms. The possible pathogenetic role of infectious agents in genetically predisposed individuals, resulting in a 'reactive osteitis% has been suggested because microbes such as Propionibacterium acnes have been recovered from bone biopsy samples. However, this hypothesis has not been demonstrated as yet. Current knowledge with regard to treatment of this syndrome is based on results reported from small case studies and, thus, is still empiric. The use of antibiotics, instituted based on the isolation of Propionibacterium acnes, has been reported to show conflicting results. Promising results for potential future application have recently been reported for treatment of SAPHO with bisphosphonates and antagonists of tumour necrosis factor-alpha. This review aims to evaluate the existing knowledge on the SAPHO syndrome and to provide information on symptoms, diagnosis and treatment options for this disease. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:423 / 434
页数:12
相关论文
共 88 条
[1]
Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30
[2]
Amital H, 2008, CLIN EXP RHEUMATOL, V26, pS27
[3]
SAPHO syndrome treated with pamidronate: an open-label study of 10 patients [J].
Amital, H ;
Applbaum, YH ;
Aamar, S ;
Daniel, N ;
Rubinow, A .
RHEUMATOLOGY, 2004, 43 (05) :658-661
[4]
Arnson Y, 2008, CLIN EXP RHEUMATOL, V26, P1119
[5]
Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome [J].
Assmann, Gunter ;
Wagner, Annette D. ;
Monika, Mueller ;
Pfoehler, Claudia ;
Pfreundschuh, Michael ;
Tilgen, Wolfgang ;
Roemer, Klaus .
RHEUMATOLOGY INTERNATIONAL, 2010, 30 (10) :1273-1276
[6]
Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study [J].
Assmann, Gunter ;
Kueck, Olaf ;
Kirchhoff, Timm ;
Rosenthal, Herbert ;
Voswinkel, Jan ;
Pfreundschuh, Michael ;
Zeidler, Henning ;
Wagner, Annette D. .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
[7]
Ballara SC, 1999, ARTHRITIS RHEUM, V42, P819
[8]
BENHAMOU CL, 1988, CLIN EXP RHEUMATOL, V6, P109
[9]
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS AND PUSTULOSIS PALMOPLANTARIS [J].
BJORKSTEN, B ;
GUSTAVSON, KH ;
ERIKSSON, B ;
LINDHOLM, A ;
NORDSTROM, S .
JOURNAL OF PEDIATRICS, 1978, 93 (02) :227-231
[10]
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years [J].
Braun, J ;
Baraliakos, X ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Burmester, G ;
Gromnica-Ihle, E ;
Kellner, H ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Sieper, J .
RHEUMATOLOGY, 2005, 44 (05) :670-676